Tag: pharmaceutical consulting

Candis Edwards: Guiding Innovation, Elevating Compliance, Advancing Global Health

I am excited to share a deeper look into my professional journey and the experiences that have shaped my passion for regulatory leadership, pharmaceutical innovation, and organizational integrity. Throughout my 45-year career, I have had the privilege of contributing to companies, teams, and missions that advance global health and patient safety. Here is my biography.

Dr. Adam J. Sagot, D.O., F.A.P.A.: Bridging Medicine, Advocacy, and Leadership for Transformative Mental Health Care

I am excited to share my professional biography, which reflects my journey across clinical psychiatry, healthcare leadership, policy advocacy, and academic medicine. Over the past decade, I’ve been fortunate to serve in executive leadership roles, teach the next generation of psychiatrists, and advocate for meaningful reforms in mental health policy. My work continues to be driven by a passion for advancing care, building healthier systems, and empowering future leaders in the field.

Sejal Jonas, PharmD, RPh | Strategic Healthcare Leader | Market Access Expert

Sejal Jonas, PharmD, RPh, is a visionary healthcare executive with over three decades of experience shaping payer strategy, formulary management, and market access for some of the nation’s leading pharmaceutical and healthcare organizations. Known for her deep clinical knowledge, strategic acumen, and commitment to improving health outcomes, Sejal brings a rare ability to bridge the gap between innovation and execution. Her work has empowered brands to thrive in complex regulatory and reimbursement environments, while her leadership continues to influence how healthcare systems deliver value to patients and providers alike.

Lain Anderson: Strategic Leader in Life Sciences and Biopharma Innovation

Lain Anderson is a seasoned leader in healthcare consulting, serving as Managing Director and Co-Head of the Americas Healthcare Sector at L.E.K. Consulting. With nearly two decades of experience advising global biopharma and life sciences companies, he specializes in corporate growth strategy, product commercialization, portfolio prioritization, and investment decision-making. Known for his strategic insight and collaborative approach, Lain helps organizations navigate the intersection of science, market opportunity, and financial performance. His background includes roles at Alnylam Pharmaceuticals and General Electric, along with academic distinction from the Tuck School of Business at Dartmouth and Boston College.